Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
June 7, 2006
Hypercholesterolemia is a potential risk factor for asthma
Baha Al-Shawwa, Nidal Al-Huniti, Gregory Titus, et al.
Clinical Pharmacokinetics
|
December 31, 2016
Clinical Pharmacokinetics and Pharmacodynamics of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist
Khanh Bui, Diansong Zhou, Hongmei Xu, et al.
Journal of Clinical Pharmacology
|
December 19, 2015
Effects of CYP3A Modulators on the Pharmacokinetics of Naloxegol
Khanh Bui, Diansong Zhou, Mark Sostek, et al.
Cancer Chemotherapy and Pharmacology
|
April 26, 2019
Resistance models to EGFR inhibition and chemotherapy in non-small cell lung cancer via analysis of tumour size dynamics
Hitesh B Mistry, Gabriel Helmlinger, Nidal Al-Huniti, et al.
British Journal of Clinical Pharmacology
|
August 29, 2015
Population pharmacokinetics of naloxegol in a population of 1247 healthy subjects and patients
Nidal Al-Huniti, Sunny Chapel, Hongmei Xu, et al.
Journal of Clinical Pharmacology
|
December 2, 2017
Physiologically Based Pharmacokinetic Modeling to Evaluate the Systemic Exposure of Gefitinib in CYP2D6 Ultrarapid Metabolizers and Extensive Metabolizers
Yingxue Chen, Diansong Zhou, Weifeng Tang, et al.
Journal of Clinical Pharmacology
|
December 3, 2015
Population Pharmacokinetic and Pharmacodynamic Modeling of AZD4901 and Simulation to Support Dose Selection for the Phase 2a Study
Hongmei Xu, Jianguo Li, Lorraine Webber, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 29, 2021
Population pharmacokinetics and exposure-response modeling for evinacumab in homozygous familial hypercholesterolemia
Xia Pu, Mark Sale, Feng Yang, et al.
Basic & Clinical Pharmacology & Toxicology
|
February 11, 2019
Physiologically based pharmacokinetic modelling to predict exposure differences in healthy volunteers and subjects with renal impairment: Ceftazidime case study
Li Zhou, Xiao Tong, Pradeep Sharma, et al.
Pharmaceutical Statistics
|
August 27, 2019
Optimal designs for regional bridging studies using the Bayesian power prior method
Mario Nagase, Shinya Ueda, Mitsuo Higashimori, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
June 7, 2006
Hypercholesterolemia is a potential risk factor for asthma
Baha Al-Shawwa, Nidal Al-Huniti, Gregory Titus, et al.
Clinical Pharmacokinetics
|
December 31, 2016
Clinical Pharmacokinetics and Pharmacodynamics of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist
Khanh Bui, Diansong Zhou, Hongmei Xu, et al.
Journal of Clinical Pharmacology
|
December 19, 2015
Effects of CYP3A Modulators on the Pharmacokinetics of Naloxegol
Khanh Bui, Diansong Zhou, Mark Sostek, et al.
Cancer Chemotherapy and Pharmacology
|
April 26, 2019
Resistance models to EGFR inhibition and chemotherapy in non-small cell lung cancer via analysis of tumour size dynamics
Hitesh B Mistry, Gabriel Helmlinger, Nidal Al-Huniti, et al.
British Journal of Clinical Pharmacology
|
August 29, 2015
Population pharmacokinetics of naloxegol in a population of 1247 healthy subjects and patients
Nidal Al-Huniti, Sunny Chapel, Hongmei Xu, et al.
Journal of Clinical Pharmacology
|
December 2, 2017
Physiologically Based Pharmacokinetic Modeling to Evaluate the Systemic Exposure of Gefitinib in CYP2D6 Ultrarapid Metabolizers and Extensive Metabolizers
Yingxue Chen, Diansong Zhou, Weifeng Tang, et al.
Journal of Clinical Pharmacology
|
December 3, 2015
Population Pharmacokinetic and Pharmacodynamic Modeling of AZD4901 and Simulation to Support Dose Selection for the Phase 2a Study
Hongmei Xu, Jianguo Li, Lorraine Webber, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 29, 2021
Population pharmacokinetics and exposure-response modeling for evinacumab in homozygous familial hypercholesterolemia
Xia Pu, Mark Sale, Feng Yang, et al.
Basic & Clinical Pharmacology & Toxicology
|
February 11, 2019
Physiologically based pharmacokinetic modelling to predict exposure differences in healthy volunteers and subjects with renal impairment: Ceftazidime case study
Li Zhou, Xiao Tong, Pradeep Sharma, et al.
Pharmaceutical Statistics
|
August 27, 2019
Optimal designs for regional bridging studies using the Bayesian power prior method
Mario Nagase, Shinya Ueda, Mitsuo Higashimori, et al.
Page
of 6